1. Introduction
- Top of page
- Abstract
- 1. Introduction
- 2. Results and Discussion
- 3. Conclusions
- 4. Experimental Section
- Supporting Information
- Acknowledgements
- Supporting Information
One of the major challenges the pharmaceutical industry is facing today is the formulation of new protein therapeutics in order to optimize their stability, activity, and efficiency for specific administration routes.1 An important strategy is the formulation of protein drugs into crosslinked aggregates such as microparticles2 and crystals3 or encapsulation by various techniques including drying and embedding into polymer matrices.4, 5 Such systems offer many advantages for example increased circulation time in the blood, protection against degradation or site specific delivery.
Another important application of protein particles is their use for biotechnological processes such as biocatalysis.6 The particle systems for these applications can be very simplistic. Often they are merely composed of crosslinked enzyme aggregates (CLEAs) without an additional carrier. Such CLEAs possess many advantages over enzyme solutions and enzymes bound to carriers: cost efficiency due to possible recovery by filtration, highly concentrated enzyme activity in the aggregate as well as high stability.7 In general they are prepared by precipitation of the protein using salts or organic solvents and subsequent covalent crosslinking by glutaraldehyde (GA) and other agents.8 Importantly, due to their porosity and the resulting high internal surface area the activity of CLEAs particles is comparable to the freely dissolved enzyme molecules.9, 10 Also combinations of enzymes such as glucose oxidase and catalase to improve activity retention of the oxidase have been documented.11 In principle such simple but highly active protein particles would also be interesting for biomedical applications. However the polydispersity of these systems prohibits clinical applications where precise control over size, porosity, surface chemistry, composition, and mechanical properties are mandatory. For example material parameters such as size, surface chemistry, and deformability greatly affect the circulation time of microparticles in the vascular system.12 Moreover, size and accessible surface area (porosity) are imperative characteristics to ensure predictable catalytic or therapeutic efficiency of the protein particles.6, 7, 9
Although porous particles composed from crosslinked proteins/enzymes have good potential in drug delivery, biotechnology and biocatalysis, the preparation challenges still impede the wide use of such systems. Typically, porous materials are prepared from emulsions,13 by solvent evaporation,14 or precipitation.15, 16 Templating techniques17, 18 are used when precise control over material properties, like composition, morphology and porosity, is desired. In principle these parameters can be controlled by selection of the template. However, templating techniques often involve harsh preparation conditions, for example pyrolysis or hydrofluoric acid etching to remove polymer18 or silica templates.19 This, as well as other techniques e.g. involving organic solvents could damage the protein structure by irreversible denaturation, deswelling and collapse of the porous scaffold. To obtain functional porous protein particles it is therefore imperative to choose templates that can be dissolved at mild conditions in aqueous media. Porous CaCO3 microparticles fulfill this requirement and have been successfully used as hard templates for the synthesis of pure pharmaceutical protein particles2, 20 and polyelectrolyte capsules containing proteins.5, 21, 22 However theses studies were not aimed to introduce and to utilize mesoporous morphologies in the particles. Here, we now want to use CaCO3-based templates but instead synthesize mesoporous protein particles.
Therefore, in the present work we exercise CaCO3 templating such, that the mesoporous structure of the CaCO3 microparticles16 is replicated as inverse structure. Using this approach we aim at crosslinked protein assemblies with well defined size, internal structure, activity and mechanical properties. To achieve this goal, a straightforward preparation procedure involving template infiltration by solvent evaporation, protein crosslinking using GA and removal of the templates by EDTA is developed. We then use optical microscopy, AFM, and SEM to analyze internal structure of various porous protein particles and investigate the applicability of hemoglobin particles as a red blood cell mimic23–25 and trypsin particles as a CLEA.26 The novel template based preparation procedure ensures a high internal surface area and deformability of the particles. Consequently, we investigate the enzymatic activity of the trypsin particles and conduct micromechanical studies on hemoglobin particles with varied crosslinker ratio to mimic the mechanical properties of red blood cells. This approach may enhance the particles’ vascular circulation time and compatibility to filtration barriers in living organisms.
3. Conclusions
- Top of page
- Abstract
- 1. Introduction
- 2. Results and Discussion
- 3. Conclusions
- 4. Experimental Section
- Supporting Information
- Acknowledgements
- Supporting Information
Taken together, infiltration of porous colloidal CaCO3 templates by drying of a protein solution followed by GA crosslinking and dissolution of the templates by EDTA allows for the preparation of porous protein particles. The method is extremely versatile in that virtually any protein can be transformed into particulate form by this approach. Furthermore the size of the particles can be conveniently controlled by the template. Analysis by optical microscopy, cryo-SEM, AFM and dextran diffusion revealed that the particles possess a well controlled morphology suggesting that the porous structure of the CaCO3 templates was successfully replicated. Moreover, we could show that the protein particles remained functional after templating. As an example we studied the activity of trypsin particles and found activities on the order of 25% as compared to non-crosslinked trypsin. The surface area of the particles can be expected to be comparable to that of the calcium carbonate templates (8 m2/g).22 This would be very useful, for example in catalysis when particles composed of enzymes are formed. In regard to industrial biocatalytic applications of the enzyme particles the long term stability as well as their repeated usage will be tested. Comparison of the elastic properties of porous particles and non-porous films made from hemoglobin indicates that the porous systems posses a low density and that the pores are stable against collapse. As a result the elastic modulus was drastically decreased for the porous particles and the particle deformation was reversible, almost completely elastic. By varying the degree of crosslinking particles with a modulus in the kPa range can be fabricated, similar to the stiffness of red blood cells, thus potentially allowing for long circulation time in the vascular system. Besides general applications as drug carrier the hemoglobin particles presented in this work may have potential as artificial red blood cell because of their suitable size and mechanical properties as well as the ability to take up oxygen. Also the high internal surface area could enhance the oxygen carrying capacity.
In future studies we will therefore further investigate oxygen binding under different partial pressures to evaluate if the of porous hemoglobin particles could act as artificial blood cells. Preparation of sub-micrometer sized protein particles by using smaller template particles39 may also enable new biomedical applications. In this regard, the cellular uptake of such smaller and soft (deformable) particles will be a focus of our future study to understand fundamental aspects of intercellular forces and applications for intracellular delivery.
4. Experimental Section
- Top of page
- Abstract
- 1. Introduction
- 2. Results and Discussion
- 3. Conclusions
- 4. Experimental Section
- Supporting Information
- Acknowledgements
- Supporting Information
Materials: All chemicals were purchased from Sigma-Aldrich (Germany). Hemoglobin, lysozyme, trypsin and FITC dextran- (500 kDa and 2000KDa) were obtained as lyophilized powder. Aliquots of GA (grade I, 25% in water) were stored at −20 °C. Sodium sulfate, and buffers where obtained as dry powder, p.a. and bioreagent grade, respectively. The calcium carbonate templates (average diameter 6.5 and 15.2 μm) were synthesized as described elsewhere.20, 22
Preparation of Porous Protein Particles: First a protein/CaCO3 template dispersion (0.5 mL, 50 mg of CaCO3) was prepared in purified water. The protein/CaCO3 weight ratio was kept constant at 7%. Then the water was removed on a rotary evaporator (150 mbar, 25 °C). After about two hours the water is completely evaporated and the templates were redispersed in 4 M Na2SO4 (pH 9, 20 mM carbonate buffer). Vigerous agitation and application of ultrasound (Elmasonic P30 H, 130 W) for two minutes then yields redispersed protein-filled CaCO3 templates. The particles were then crosslinked via GA at a concentration of 0.00025-–.025 M which translates to 0.003-0.3 w/w with respect to the protein. After three-fold centrifugation and washing the CaCO3 templates were dissolved in 0.2 M EDTA (pH 8, NaOH adjusted). Finally, residual EDTA, the complex Ca-EDTA and bicarbonate were removed by dialysis in PBS using Float-A-Lyzers G2 with a size cutoff of 50 kD (Spectrum Laboratories Inc, USA).
Microscopy: Optical microscopy was conducted on an Olympus IX 51 equipped with a Zeiss HRm camera. Phase contrast and fluorescence images were collected with a 20× Objective (PLN 20XPH, N.A. 0.4, Olympus, Japan). High resolution optical images were taken in brightfield with a 63× Objective (Antiflex Neofluar, N.A. 1.45, Zeiss, Germany). The porosity of CaCO3 templates and protein particles was investigated utilizing a scanning electron microscope (SEM) LEO 1550 operating at 3 kV, a scanning electron microscope JEOL JSM-7500F operating at 2 kV for cryogenic study (cryo-SEM) and a transmission electron microscope (TEM) Zeiss EM 912 Omega operating at 120 kV. AFM imaging of dried protein particles was conducted with a Nanowizard I (JPK instruments AG, Germany) in tapping mode using a standard silicon cantilever with a nominal spring constant of 40 N/m (NSC16, MicroMash, Estonia).
Permeability Studies: The porosity of the protein particles was tested in a permeability study using FITC-labeled dextran of different molecular weight 500 kDa and 2000 kDa. The dextrans were added to the protein particles suspension to obtain a dextran concentration about 1 μg/mL. Then CLSM micrographs were taken with a Leica confocal scanning system mounted on a Leica Aristoplan apparatus and quipped with a 100× oil immersion objective (numerical aperture 1.4) From the images the fluorescence intensity within more than 20 particles was determined using image processing (ImageJ 1.4, NHS, USA). The data was normalized using the background fluorescence intensity. In the time frame of the image acquisition (2 h) and after incubation over night no changes in the particles fluorescence were observed.
Micromechanical Characterization: The elastic properties of the protein particles were measured via colloidal probe AFM. As force probe we used colloidal silica particles (Microparticles GmbH, Berlin, Germany) with a diameter of 30 μm glued to the apex of the AFM cantilevers with a spring constant of 0.03 N/m (CSC12, tipless, MicroMash, Estonia). Prior to the probe attachment the spring constant was determined according to the thermal noise40 and the Sader41 method. The cantilevers showed deviation between both methods of less than 10% to qualify for force measurements. The protein particles were allowed to sediment and adhere onto a polyethyleneimine coated coverslip35 by which they are immobilized. The AFM head is mounted on an optical microscope (IX51, Olympus, Japan). Using bright field optics and also using the autofluorescence of the protein particles the colloidal probe was positioned at the apex of the microgels in order to perform the AFM force measurement. The measurement was conducted using an approach speed of 1 μm/s applying peak forces of 12 nN. The deformation of the particles upon hydrodynamic flow in microchannels involved preparation of a polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning Germany) stamp from a lithographic silicon master with 3 μm grating (GeSim mbH, Germany) as described in.42 The PDMS channels were covered with a glass coverslip. Capillary action drew the micrometer-sized protein particles into the channels (see Figure 5C) after placing a droplet of the particle dispersion near the rim of the coverslip. The deformed particles in the channels were then imaged by optical microscopy.
Enzymatic Activity of Trypsin Particles: The activity of porous trypsin particles was determined at 25 °C in 50 mM phosphate buffer, pH 7.4 using N-benzoyl-l-arginine ethyl ester (BAEE) as a substrate.32 At BAEE excess concentration the conversion rate was compared to trypsin standard solutions to obtain a relative activity. The concentration of the trypsin in solution and in particulate form was 0.625 μg/mL during the photometric assay. Residual enzymatic activity in the supernatant of centrifuged particle dispersion was less than 1% compared to the particle suspension. The measurements were conducted on a JASCO V 400 spectrophotometer at 514 nm.